Paper37849802
The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma.
Zhai X and 6 others. Front Oncol, 2023. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma. Papers, record 37849802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37849802
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35326557 | Angiogenesis Inhibitors and Immunomodulation in Renal Cell Cancers: The Past, Present, and Future. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35326557 | PubMed |
| 2 | 30672334 | Clear Cell Papillary Renal Cell Carcinoma. | Arch Pathol Lab Med | 2019 | https://conductscience.org/library/papers/30672334 | PubMed |
| 3 | 30799404 | Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options. | Oncol Res Treat | 2019 | https://conductscience.org/library/papers/30799404 | PubMed |
| 4 | 32251007 | Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer. | Am J Surg Pathol | 2020 | https://conductscience.org/library/papers/32251007 | PubMed |
| 5 | 31278395 | The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications. | Nat Rev Urol | 2019 | https://conductscience.org/library/papers/31278395 | PubMed |
| 6 | 29967214 | Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies. | Mol Cancer Ther | 2018 | https://conductscience.org/library/papers/29967214 | PubMed |
| 7 | 34991918 | Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis. | Eur Urol | 2022 | https://conductscience.org/library/papers/34991918 | PubMed |
| 8 | 35203461 | The Frontline Immunotherapy-Based Treatment of Advanced Clear Cell Renal Cell Carcinoma: Current Evidence and Clinical Perspective. | Biomedicines | 2022 | https://conductscience.org/library/papers/35203461 | PubMed |
| 9 | 33818540 | A challenging frontier - the genomics and therapeutics of nonclear cell renal cell carcinoma. | Curr Opin Oncol | 2021 | https://conductscience.org/library/papers/33818540 | PubMed |
| 10 | 36230613 | Identification and Validation of a Novel Ferroptotic Prognostic Genes-Based Signature of Clear Cell Renal Cell Carcinoma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36230613 | PubMed |
| 11 | 34439293 | Clearing up Clear Cell: Clarifying the Immuno-Oncology Treatment Landscape for Metastatic Clear Cell RCC. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34439293 | PubMed |
| 12 | 36816976 | The role of immunotherapy in non-clear cell renal cell carcinoma. | Front Oncol | 2023 | https://conductscience.org/library/papers/36816976 | PubMed |
| 13 | 33753250 | Comprehensive review of chromophobe renal cell carcinoma. | Crit Rev Oncol Hematol | 2021 | https://conductscience.org/library/papers/33753250 | PubMed |
| 14 | 34359554 | Immune Checkpoint Inhibition in Advanced Non-Clear Cell Renal Cell Carcinoma: Leveraging Success from Clear Cell Histology into New Opportunities. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34359554 | PubMed |
| 15 | 34527080 | New approaches to first-line treatment of advanced renal cell carcinoma. | Ther Adv Med Oncol | 2021 | https://conductscience.org/library/papers/34527080 | PubMed |
| 16 | 28276433 | Renal cell carcinoma. | Nat Rev Dis Primers | 2017 | https://conductscience.org/library/papers/28276433 | PubMed |
| 17 | 32733094 | The immunology of renal cell carcinoma. | Nat Rev Nephrol | 2020 | https://conductscience.org/library/papers/32733094 | PubMed |
| 18 | 33536782 | Expression and Role of Dickkopf-1 (Dkk1) in Tumors: From the Cells to the Patients. | Cancer Manag Res | 2021 | https://conductscience.org/library/papers/33536782 | PubMed |
Genes46
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37849802
GET https://conductscience.org/api/papers/v1/37849802/genes?page=2